Characteristics of late HIV diagnosis in Germany in 2019 and 2020 - A regional analysis
27 affiliations
- 1Institute of Infectious Diseases and Infection Control, Jena University Hospital, Friedrich-Schiller-University, Jena, Germany
- 2Department of Psychosomatic Medicine and Psychotherapy, Jena University Hospital, Friedrich-Schiller-University, Jena, Germany
- 3ICH Study Center Hamburg, Hamburg, Germany
- 4Infektiologikum Frankfurt, Frankfurt Am Main, Germany
- 5Department of Internal Medicine, Infectious Diseases, University Hospital Frankfurt, Frankfurt Am Main, Germany
- 6Clinic for Infectious Diseases, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
- 7MVZ München Am Goetheplatz, Munich, Germany
- 8Department of Infectious and Respiratory Medicine, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Berlin, Germany
- 9Department of Infectious Diseases, Vivantes Auguste-Viktoria-Klinikum, Berlin, Germany
- 10Praxis Georgstrasse, Hanover, Germany
- 11Clinical Department of Internal Medicine II, TUM School of Medicine and Health, TUM University Hospital, Munich, Germany
- 12Second Medical Department, University Hospital Schleswig-Holstein, Kiel, Germany
- 13Department of Medicine I, University Hospital Bonn, Bonn, Germany
- 14Center for Infectiology Berlin-Prenzlauer Berg, Berlin, Germany
- 15MVZ Infektiologie Ärzteforum Seestrasse, Berlin, Germany
- 16Diabeteszentrum Erfurt, Erfurt, Germany
- 17Department of Infectious Diseases, St. Joseph Hospital, Berlin-Tempelhof, Berlin, Germany
- 18Division of Infectious Diseases and Tropical Medicine, Department of Medicine I, Leipzig University Medical Center, Leipzig, Germany
- 19Medcenter Chemnitz, Chemnitz, Germany
- 20Praxis Am Ebertplatz, Cologne, Germany
- 21Department I of Internal Medicine, Faculty of Medicine, University Hospital Cologne, Cologne, Germany
- 22Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-Von-Guericke University Magdeburg, Magdeburg, Germany
- 23Praxis Dr. Ruck, Leipzig, Germany
- 24Arztpraxis Rößler, Zwickau, Germany
- 25Laboratory Dr. Knechten, Medical Center for HIV and Hepatitis, Aachen, Germany
- 26Medcenter Leipzig, Leipzig, Germany
- 27Medcenter Weimar, Weimar, Germany
Abstract
Purpose: A large proportion of HIV diagnoses are made at an advanced stage of infection and different patient characteristics have been associated with late diagnosis of HIV. This study aims to assess the prevalence of late HIV diagnosis, to characterize individuals diagnosed at a late stage of infection and to evaluate regional differences in Germany.
Methods: This retrospective, cross-sectional analysis included 1,169 individuals newly diagnosed with HIV in 2019 and 2020. Data on patient demographics, information on the HIV diagnosis and laboratory parameters were collected. Late diagnosis and advanced HIV disease were defined according to established consensus criteria. Regional comparison was made between eastern and western Germany.
Results: In our cohort, 82.6% of the individuals were male and 16.9% female, with a median age of 39 years (IQR: 31–50). The prevalence of late diagnosis was 61.6% and advanced HIV disease, as a subgroup of late diagnosis, was present in 41.7%. Individuals with late diagnosis were significantly older than those diagnosed at an earlier stage (p < 0.001). Patients in eastern Germany were diagnosed at more advanced stages of infection with significantly higher rates of late diagnosis (p < 0.01), advanced HIV disease (p < 0.001), and AIDS-defining conditions (p < 0.001), as well as significantly lower CD4 cell counts (p < 0.001).
Conclusion: Our data demonstrate that a high proportion of HIV diagnoses in Germany are made at a late stage of infection. Late diagnosis was more frequent in older individuals and in those living in eastern Germany. These findings highlight the need for strengthened HIV testing strategies, particularly in underserved populations and regions.
Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1007/s15010-026-02935-3.
Related
- The regional drivers of heat susceptibility in Germany
- Data Completeness and Recorded Advanced HIV Categories in a Regional Registry Extract from Northwestern Romania: A Retrospective Audit of 192 Records and Diagnosis Trends, 2013–2023
- Early vs late fusion of qMIDS with machine learning based classifiers for oral cancer diagnosis from gene expression data
- MRI diagnosis of concurrent perforated appendicitis and acute calculous cholecystitis in late pregnancy: a case report
- Late HIV diagnosis: An application of flexible Bayesian approaches to understand associated factors and time to diagnosis in Ireland, 2015–2024
BibTeX
@article{helbig2026characteristics,
title = {{Characteristics of late HIV diagnosis in Germany in 2019 and 2020 - A regional analysis}},
author = {Carlotta Helbig and Susanne Mohr and Mathias W. Pletz and Juliane Ankert and Jens Forthmann and Markus Bickel and Christoph Stephan and Olaf Degen and Sebastian Noe and Hans Wesselmann and Daniela Tominski and Stefanie Holm and Christoph Spinner and Neel Petersen and Christoph Boesecke and Axel Baumgarten and Wolfgang Schmidt and Sven Becker and Hartmut Stocker and Christoph Lübbert and Thomas Heuchel and Christoph Wyen and Wilfried Obst and Ines Ruck and Steve Rößler and Heribert Knechten and Michael Waizmann and Thomas Seidel and Benjamin T. Schleenvoigt},
journal = {Infection},
year = {2026},
month = aug,
doi = {10.1007/s15010-026-02935-3},
url = {https://doi.org/10.1007/s15010-026-02935-3},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Characteristics of late HIV diagnosis in Germany in 2019 and 2020 - A regional analysis
AU - Carlotta Helbig
AU - Susanne Mohr
AU - Mathias W. Pletz
AU - Juliane Ankert
AU - Jens Forthmann
AU - Markus Bickel
AU - Christoph Stephan
AU - Olaf Degen
AU - Sebastian Noe
AU - Hans Wesselmann
AU - Daniela Tominski
AU - Stefanie Holm
AU - Christoph Spinner
AU - Neel Petersen
AU - Christoph Boesecke
AU - Axel Baumgarten
AU - Wolfgang Schmidt
AU - Sven Becker
AU - Hartmut Stocker
AU - Christoph Lübbert
AU - Thomas Heuchel
AU - Christoph Wyen
AU - Wilfried Obst
AU - Ines Ruck
AU - Steve Rößler
AU - Heribert Knechten
AU - Michael Waizmann
AU - Thomas Seidel
AU - Benjamin T. Schleenvoigt
PY - 2026
DA - 2026/08/25
JO - Infection
DO - 10.1007/s15010-026-02935-3
UR - https://doi.org/10.1007/s15010-026-02935-3
AB - Purpose: A large proportion of HIV diagnoses are made at an advanced stage of infection and different patient characteristics have been associated with late diagnosis of HIV. This study aims to assess the prevalence of late HIV diagnosis, to characterize individuals diagnosed at a late stage of infection and to evaluate regional differences in Germany. Methods: This retrospective, cross-sectional analysis included 1,169 individuals newly diagnosed with HIV in 2019 and 2020. Data on patient demographics, information on the HIV diagnosis and laboratory parameters were collected. Late diagnosis and advanced HIV disease were defined according to established consensus criteria. Regional comparison was made between eastern and western Germany. Results: In our cohort, 82.6% of the individuals were male and 16.9% female, with a median age of 39 years (IQR: 31–50). The prevalence of late diagnosis was 61.6% and advanced HIV disease, as a subgroup of late diagnosis, was present in 41.7%. Individuals with late diagnosis were significantly older than those diagnosed at an earlier stage (p < 0.001). Patients in eastern Germany were diagnosed at more advanced stages of infection with significantly higher rates of late diagnosis (p < 0.01), advanced HIV disease (p < 0.001), and AIDS-defining conditions (p < 0.001), as well as significantly lower CD4 cell counts (p < 0.001). Conclusion: Our data demonstrate that a high proportion of HIV diagnoses in Germany are made at a late stage of infection. Late diagnosis was more frequent in older individuals and in those living in eastern Germany. These findings highlight the need for strengthened HIV testing strategies, particularly in underserved populations and regions. Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1007/s15010-026-02935-3.
SN - 0300-8126
SN - 1439-0973
ER -